SynthesisEuropean journal of cancer (Oxford, England : 1990)2022

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.

Anthony M Joshua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.